Clene (CLNN) EBITDA Margin (2020 - 2026)
Clene's EBITDA Margin was -5548.89% in Q2 2026, up 14947.41 percentage points from -20496.30% a year earlier.
Powered by 
Analysis
Clene (CLNN) EBITDA Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Clene's EBITDA Margin was -10981.34% through Jun 30, 2026, down 2276.44 percentage points year-over-year; for FY2025, it came in at -10802.50%, down 1605.13 percentage points from FY2024.
- EBITDA Margin shows a five-year change of -1457.35 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was -9197.37% in FY2024 (-3259.30 pp), -5938.07% in FY2023 (+4080.95 pp), -10019.03% in FY2022 (-3235.49 pp) and -6783.54% in FY2021 (+2561.60 pp).
- The Q2 2026 figure marks the highest quarterly EBITDA Margin since Q1 2025.
- Compared with a year earlier, EBITDA Margin was higher in two of the last seven quarters, with an average year-over-year change of -2976.40 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q2 2023 (a gain of 34359.08 percentage points); the worst was Q1 2022 (a drop of 38424.93 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 39.16% |
| 10 | Clene | 48.35 Mn | 18.28 Mn | 54,000.00 | -5,548.89% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5,548.89% |
| Dec 31, 2025 | -8,900.00% |
| Sep 30, 2025 | -33,540.00% |
| Jun 30, 2025 | -19,566.67% |
| Mar 31, 2025 | -4,270.37% |
| Dec 31, 2024 | -9,121.98% |
| Sep 30, 2024 | -8,054.02% |
| Jun 30, 2024 | -7,220.88% |
| Mar 31, 2024 | -11,568.49% |
| Dec 31, 2023 | -5,398.24% |
| Sep 30, 2023 | -8,140.74% |
| Jun 30, 2023 | -3,582.16% |
| Mar 31, 2023 | -9,420.56% |
| Dec 31, 2022 | -4,772.22% |
| Sep 30, 2022 | -5,375.29% |
| Jun 30, 2022 | -37,422.86% |
| Mar 31, 2022 | -43,046.67% |
| Dec 31, 2021 | -6,795.48% |
| Sep 30, 2021 | -9,331.82% |
| Jun 30, 2021 | -6,738.81% |
API Access
Clene EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CLNN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CLNN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CLNN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();